The Management of Ocular Surface Squamous Neoplasia (OSSN)

The Management of Ocular Surface Squamous Neoplasia (OSSN)

The rise of primary topical monotherapy with chemotherapeutic drugs and immunomodulatory agents represents an increasing recognition of the medical management of ocular surface squamous neoplasia (OSSN), which may replace surgery as the standard of care in the future. Currently, there is no consensu...

Full description

Bibliographic Details
Main Authors: Clarice H. Y. Yeoh, Jerome J. R. Lee, Blanche X. H. Lim, Gangadhara Sundar, Jodhbir S. Mehta, Anita S. Y. Chan, Dawn K. A. Lim, Stephanie L. Watson, Santosh G. Honavar, Ray Manotosh, Chris H. L. Lim
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:International Journal of Molecular Sciences
Subjects:
ocular surface squamous neoplasia
management
topical chemotherapy
5-fluorouracil (5-FU)
mitomycin C (MMC)
interferon alfa (INFα)
Online Access:https://www.mdpi.com/1422-0067/24/1/713

Internet

https://www.mdpi.com/1422-0067/24/1/713

Similar Items